Cholera Outbreak Reported in Ivory Coast with Seven Fatalities

Ivory Coast has confirmed a cholera outbreak near Abidjan, with seven deaths and over 45 cases reported, highlighting ongoing sanitation challenges and global health risks.
Ivory Coast has declared an outbreak of cholera, resulting in the confirmation of seven deaths linked to the disease. The National Institute of Public Hygiene announced that stool sample analyses conducted by the Pasteur Institute of Côte d'Ivoire identified Vibrio cholerae, the bacteria responsible for cholera. The outbreak was first reported on May 25, 2025, in the Port-Bouët-Vridi health district, specifically in the village of Vridi Akobrate near Abidjan. In this community, five deaths occurred within the first two days of detection, with a total of 45 cases recorded so far, including the seven fatalities. All deaths happened within the community during that initial period.
Cholera has been recurrent in Ivory Coast since the 1990s, often fueled by poor sanitation and limited access to clean water. The World Health Organization classifies cholera as a disease of poverty, which predominantly affects regions with inadequate sanitation infrastructure. Africa faces a heightened risk, especially amid climate change impacts, the El Niño weather phenomenon, and current global vaccine shortages. These factors contribute to the increased vulnerability of the continent to cholera outbreaks.
Health officials urge the population to remain vigilant by consuming safe drinking water, avoiding contaminated street water, and practicing regular handwashing to curb the spread of the disease. The government emphasizes the importance of hygiene and sanitation measures to prevent further cases during this outbreak.
Source: https://medicalxpress.com/news/2025-06-ivory-coast-cholera-outbreak-deaths.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Reevaluating 'Preventable' Deaths: Uncovering Systemic Barriers to Healthcare Access
Preventable deaths in the U.S. often mask systemic barriers to healthcare access, highlighting the need to understand structural factors behind health outcomes rather than solely individual responsibility.
FDA Approves First Treatment for Rare Mitochondrial Disease Barth Syndrome
The FDA has approved Forzinity, the first treatment for Barth syndrome, a rare mitochondrial disease, highlighting advances in therapy for this life-threatening condition.
Molecular Mapping Sheds Light on How Benign Borderline Ovarian Tumors Turn Invasive
Innovative spatial proteomics techniques reveal how benign borderline ovarian tumors progress to invasive cancer, uncovering new molecular targets and therapeutic strategies.
Understanding the Link Between Tylenol Use During Pregnancy and Autism: Distinguishing Correlation from Causation
Recent studies explore the potential link between Tylenol use during pregnancy and autism, emphasizing the distinction between association and causation in scientific research. Current evidence remains inconclusive, urging medical guidance and further investigation.



